A Comparative Study of Trigger Point Therapy with Local Anaesthetic (0.5 % Bupivacaine) Versus Combined Trigger Point Injection Therapy and Levosulpiride in the Management of Myofascial Pain Syndrome in the Orofacial Region
- 180 Downloads
To compare the efficacy of combined local anesthetic injection with 0.5 % bupivacaine and levosulpiride versus local anesthetic injection alone on outcome measures including levels of pain intensity and depression in the management of myofascial pain syndrome in orofacial region.
Patients and Methods
This was a prospective, randomized, controlled and open-label comparative clinical study. Seventy-four patients diagnosed to have myofascial pain syndrome and fulfilling the inclusion criteria were enrolled for the study. Patients were randomly assigned into 2 groups. Group A received local anesthetic injection (0.5 % bupivacaine) on trigger points and Group B received combined trigger point injection therapy and 50 mg of tablet Levosulpiride orally B.I.D. They were assessed for pain intensity and depression at baseline and at follow-up of 1, 4, 6 and 12 week intervals.
The mean age of patients was 44.54 + 15.977 years in group A and 39.97 + 14.107 years in group B (P value = 0.2). Group A comprised of 25 females (67.567 %) and 12 males (32.432 %) while group B had 27 females (75 %) and 9 males (25 %). 70.27 % were diagnosed with moderate depression in group A and 75 % in group B. 18.91 % in group A and 19.44 % in group B were diagnosed with severe depression. When the VAS score and BDI score was compared at the follow-up intervals with the baseline scores in both treatment groups, the mean difference was highly significant at all the follow-up intervals. However when the relative efficacies of two interventions were compared between the two groups, improvement in pain was significant at all the follow-up intervals except the 1st week follow-up whereas the improvement in depression was non-significant at 1st and 4th week interval while it was highly significant at 6th and 12th week intervals.
The combined therapy with trigger point injection and levosulpiride as antidepressant significantly reduces pain and depression in the study subjects suffering from chronic myofascial pain with moderate to severe depression in the orofacial region.
KeywordsMyofascial pain Temporomandibular disorders Masticatory muscles Orofacial region Depression
- 1.Gerwin RD, Dommerholt J (2002) Treatment of myofascial pain syndromes. In: Weiner R (ed) Pain management; a practical guide for clinicians. CRC Press, Boca Raton, pp 235–249Google Scholar
- 2.Dommerholt J (2001) Muscle pain syndromes. In: Cantu RI, Grodin AJ (eds) Myofascial manipulation. Aspen, Gaithersburg, pp 93–140Google Scholar
- 3.Dworkin SF (2001) Psychosocial issues. In: Lund JP (ed) Orofacial pain, from basic science to clinical management – the transfer of knowledge in pain research to education. Quintessence Pub. Co. Inc., pp 115–127Google Scholar
- 4.Simons DG, Travell JG, Simons LS, Travell JG (1999) Travell & Simons’ myofascial pain and dysfunction: the trigger point manual, 2nd edn. Williams & Wilkins, BaltimoreGoogle Scholar
- 6.Beck AT, Steer RA (2000) Beck depression inventory (BDI). In: Rush AJ (ed) Handbook of psychiatric measures, 1st edn. American Psychiatric Press, Washington, pp 534–537Google Scholar
- 9.Drangsholt M, LeResche L (1999) Temporomandibular disorder pain. In: Crombie IK et al (eds) Epidemiology of pain. IASP Press, Seattle, pp 203–233Google Scholar